Title: Barriers to Providing Health Services for HIV/AIDS, Hepatitis C Virus Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs in the United States Edmund J. Bini, MD, MPH1, Steven Kritz, MD2, Lawrence S. Brown, Jr, MD,
1Barriers to Providing Health Services for
HIV/AIDS, Hepatitis C Virus Infection, and
Sexually Transmitted Infections in Substance
Abuse Treatment Programs in the United
StatesEdmund J. Bini, MD, MPH1, Steven Kritz,
MD2, Lawrence S. Brown, Jr, MD, MPH2,3, Jim
Robinson, MEd4, Don Alderson, MS5, John Rotrosen,
MD61Division of Gastroenterology, VA New York
Harbor Healthcare System and New York University
School of Medicine, New York, NY 2Addiction
Research and Treatment Corporation, Brooklyn, NY
3Department of Public Health, Weill Medical
College, Cornell University, New York, NY
4Nathan Kline Institute, Orangeburg, NY 5New
York State Psychiatric Institute, New York, NY
6Department of Psychiatry, VA New York Harbor
Healthcare System and New York University School
of Medicine, New York, NY
Methods
Results
Results
Background Aim
- To assess barriers to delivering health services
for the 3 targeted infections, program
administrators were provided with a list of 7
barriers and were asked to choose yes or no for
each of the 7 barriers to delivering each of the
4 medical and 4 non-medical services - The treatment program clinician surveys were sent
by mail to 2,210 randomly selected clinicians at
each of the programs - The questions that assessed clinician barriers
were identical to the questions in the program
administrator survey
- Human immunodeficiency virus (HIV), hepatitis C
virus (HCV), and sexually transmitted infections
(STI) are major public health problems worldwide - The use and abuse of illicit substances is also a
major public health problem, and substance abuse
is largely responsible for sustaining the
epidemics of HIV, HCV, and STI in the United
States - To date, however, the limited multicenter data
that are available demonstrate that HIV/AIDS,
HCV, and STI health services are not universally
available in all drug treatment programs - The reasons why these services are not offered
are unknown - The primary aim of this study was to determine
barriers to offering health services for
HIV/AIDS, HCV, and STI within substance abuse
treatment programs in the United States
HIV/AIDS, HCV, and STI Services Offered by the
269 Substance Abuse Programs
Barriers to Providing HIV/AIDS, HCV, and STI
Services Reported by Program Administrators
HIV/AIDS Services Offered HCV Services Offered STI Services Offered P-Value
Patient medical history and physical exam 59.8 52.9 51.6 0.14
Patient biological testing 52.4 36.8 42.2 lt0.01
Patient treatment 41.5 30.8 35.8 0.04
Patient monitoring 47.4 37.5 41.2 0.08
Provider education 73.2 67.3 60.8 0.01
Patient education 89.3 78.4 80.1 lt0.01
Patient risk assessment 88.5 75.8 76.5 lt0.01
Patient counseling 71.8 62.4 63.7 0.06
Medical Services Medical Services Medical Services Medical Services Non-Medical Services Non-Medical Services Non-Medical Services Non-Medical Services
Barriers to Providing Services Patient Medical History and Physical Exam Patient Biological Testing Patient Treatment Patient Monitoring Provider Education Patient Education Patient Risk Assessment Patient Counseling
HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS HIV/AIDS
Government regulations 11.8 16.0 17.9 14.3 9.4 9.1 5.8 10.5
Treatment program policies 14.2 18.3 19.2 18.4 8.2 7.4 7.1 11.3
Staff training 27.0 29.2 34.9 34.0 41.5 39.4 32.8 39.5
Funding 56.7 63.8 70.4 64.9 64.2 58.4 47.9 62.0
Patient/client health insurance benefits 48.3 52.1 58.6 53.8 34.6 42.3 35.8 51.9
Patient/client acceptance 32.8 37.3 41.4 39.3 17.0 38.6 33.8 43.3
Staff acceptance 11.0 16.5 14.3 16.0 13.3 13.0 11.3 15.9
Other barriers 4.8 3.4 8.2 6.5 3.4 5.4 2.1 6.7
HCV HCV HCV HCV HCV HCV HCV HCV HCV
Government regulations 13.2 14.2 15.7 16.3 7.4 7.0 5.7 8.7
Treatment program policies 11.8 20.7 22.9 20.6 8.3 7.0 8.3 12.3
Staff training 27.6 31.7 39.6 36.8 41.3 44.7 36.2 43.9
Funding 55.3 65.1 71.7 63.4 65.2 61.5 48.5 60.3
Patient/client health insurance benefits 49.1 57.1 59.4 53.9 34.3 42.1 35.6 48.7
Patient/client acceptance 33.8 39.8 47.8 43.7 13.0 33.8 31.0 39.7
Staff acceptance 11.8 16.4 17.0 17.5 12.2 12.4 12.7 14.2
Other barriers 8.3 10.3 8.8 8.6 6.9 7.6 4.1 8.2
STI STI STI STI STI STI STI STI STI
Government regulations 11.7 14.7 14.2 12.3 8.1 10.3 8.2 10.8
Treatment program policies 13.7 20.3 16.4 17.8 10.2 13.2 9.4 12.0
Staff training 31.8 31.9 36.1 31.9 42.2 45.1 33.8 41.3
Funding 53.4 59.2 63.8 57.8 62.3 59.7 50.8 59.0
Patient/client health insurance benefits 47.4 53.0 55.2 50.4 32.3 41.6 36.4 49.8
Patient/client acceptance 33.8 36.2 37.4 39.5 14.8 34.8 35.5 40.9
Staff acceptance 11.7 16.5 16.0 15.8 13.3 14.2 10.3 15.5
Other barriers 6.6 6.6 6.6 6.5 6.7 4.8 5.2 7.9
Results
Median Number of the 8 Health Services Offered
for HIV/AIDS, HCV, and STI
- Completed surveys were received from
- 269 of the 319 program administrators (84.3)
- 1,723 of the 2,210 clinicians (78.0)
P lt0.01
Methods
Characteristics of the 269 Substance Abuse
Programs
Characteristic Percent
Corporate structure Private not-for-profit Private for-profit Government Other 78.7 5.6 13.4 2.2
Nature of the program Hospital/Medical School/University Mental Health/Family/Child Services Center Free-Standing Other 13.9 12.7 60.7 12.7
Largest source of revenue County/local grants State funds Medicaid Federal grants Other 17.2 39.3 17.6 12.6 13.4
Addiction services offered Inpatient or residential services Outpatient pharmacotherapy Other outpatient services Outreach support services 55.0 36.8 80.2 87.6
Medical staff (MD, PA, NP, RN, LPN, etc.) 0 1 3 4 or more 21.1 36.4 42.5
Non-medical staff 0 7 8 17 18 or more 30.3 45.2 24.5
Current patient census 0 1 500 501 1,000 1,000 or more 2.0 56.9 20.4 20.8
Percent of patients infected with HIV 0 1 10 11 20 21 or more 12.4 65.7 12.4 9.6
Percent of patients infected with HCV 0 1 10 11 20 21 or more 9.2 30.1 12.1 48.6
Percent of patients infected with STI 0 1 10 11 20 21 or more 8.3 57.5 15.0 19.2
- The target population for this study included
treatment program administrators (program
directors or managers) and treatment program
clinicians in all substance abuse treatment
programs within the National Drug Abuse Treatment
Clinical Trials Network (CTN) in the United
States - The CTN includes a large number of treatment
programs whose mission is to improve the quality
of drug abuse treatment throughout the country
using evidence-based medicine and science as the
vehicle - The treatment program administrator surveys were
sent by mail to each of the administrators of the
319 treatment programs within the CTN - This comprehensive survey assessed the structure
of the treatment program, staffing, funding,
characteristics of the patients enrolled in the
program, services offered for HIV/AIDS, HCV, and
STI, and barriers to offering services for these
infections - For each of the 3 infections, we assessed the
availability of 8 health services (offered either
on-site or by contractual agreement with another
provider), including - 4 medical services (medical history/physical
examination, biological testing, medical
treatment, medical monitoring) - 4 non-medical services (provider education,
patient education, patient risk assessment,
patient counseling)
Proportion of Programs That Did Not Offer Any of
the 4 Medical or 4 Non-Medical Services for
HIV/AIDS, HCV, and STI
No Medical Services
No Non-Medical Services
P lt0.01
P lt0.01
References
Conclusions
- Health service delivery for HIV/AIDS, HCV, and
STI is less than optimal in drug treatment
programs in the United States - There are numerous barriers to providing these
services - Public health interventions to overcome barriers
to care afford an opportunity to enhance
treatment and prevention of these infections
- The frequency and types of barriers reported by
program administrators and clinicians were
similar - Only the barriers reported by the program
administrators are presented